pH-balance tonic as a gift with a one-time purchase of over 220€
Change regional settings
for the treatment of angiopathy, glaucoma, cataracts
The isolated peptides prevent the development of retinal degeneration, normalize metabolism and prevent the development of retinal degeneration and optic nerve atrophy.
*In case of wet macular degeneration, edema, hemorrhages in the retina, only Visoluten and Retisil can be used. In retinal sclerosis (fibrosis), the use of retinal peptides is contraindicated.
Revilab ML 03 | Prevent optic nerve atrophy |
Pinalex | Prevent retinal degeneration |
Visoluten №60 | Prevent the development of the retinal degeneration |
Церлутен №60 | Prevent the development of the retinal degeneration |
Ventfort №60 | Normalizes the condition of the vascular wall |
Visoluten №60 | Prevent the development of the retinal degeneration |
Церлутен №60 | Prevent the development of the retinal degeneration |
Ventfort №60 | Normalizes the condition of the vascular wall |
Revilab SL 02 | It normalizes vascular permeability; reduces the appearance of local inflammatory reaction; stimulates repair processes in diseases and injuries of the retina. |
Pinalex Tab | Stimulation of regenerative processes in the eye tissues at increased fatigue, diseases accompanied by decreased visual activity |
Revilab ML 03 | Prevent optic nerve atrophy |
Pinalex | Prevent retinal degeneration |
Visoluten №60 | Prevent the development of the retinal degeneration |
Церлутен №60 | Prevent the development of the retinal degeneration |
Ventfort №60 | Normalizes the condition of the vascular wall |
Visoluten №60 | Prevent the development of the retinal degeneration |
Церлутен №60 | Prevent the development of the retinal degeneration |
Ventfort №60 | Normalizes the condition of the vascular wall |
Revilab SL 02 | It normalizes vascular permeability; reduces the appearance of local inflammatory reaction; stimulates repair processes in diseases and injuries of the retina. |
Pinalex Tab | Stimulation of regenerative processes in the eye tissues at increased fatigue, diseases accompanied by decreased visual activity |
Title | Quantity | Directions for use | Mechanism of action | ||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
|